Pharmaceutical Sciences Division News Today

A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.

This Week in Washington: House Energy and Commerce Committee markup includes 19 healthcare bills; Senate HELP Committee to mark up SUPPORT Act Reauthorization and three other bills;...

A research question posed in Pankaj Desai's lab has led to a decade of research, a clinical trial and major national funding to further investigate a potential new treatment for the most deadly form of brain tumors.

Glioblastoma nearly invariably recurs, generally months after the first brain tumour is surgically removed from the patient. It's as tough as the harshest

In most cases, months after the patients first tumour is surgically removed, glioblastoma recurs, like the hardest weed

Like the toughest weed, Glioblastoma almost always returns, typically months after the patients initial brain tumour is surgically removed

Get latest articles and stories on Health at LatestLY. Like the toughest weed, Glioblastoma almost always returns, typically months after the patients initial brain tumour is surgically removed. Because of this, the survival rates for this cancer are only 25% after one year and drop to 5% after five years. Health News | New Injectable Gel Holds Promise for Tough-to-treat Brain Tumours.

Glioblastoma nearly invariably recurs, generally months after the first brain tumour is surgically removed from the patient. It's as tough as the harshest